Hatch.Bio Labs Introduces Advanced Vivarium Facility Following Successful Site Launch

Experienced Team Expands Industry-Leading Biotech Hub with Fully Integrated Services, Core Equipment, and Newly Opened Vivarium

SOMERVILLE, Mass., July 22, 2025 /PRNewswire/ -- Hatch.Bio Labs announces the launch of its vivarium facility, located conveniently on the same floor as its next-generation 50,000-square-foot biotech incubation platform. This flagship incubation facility is located at 100 Chestnut Street in Somerville, Massachusetts, a new building developed by North River Leerink, and has welcomed fifteen resident companies since opening in August last year.

Biotechnology and life sciences companies face unique operational and logistical challenges as they scale, which can distract them from the development of impactful therapeutics and biotechnologies. Incubator-style shared laboratory environments have become the go-to launchpad for these high-growth, early-stage companies. However, the incubator model has stagnated in recent years, with many unaddressed operational, logistical, and financial hurdles.

Hatch.Bio Labs's first-in-class incubator and vivarium facility was developed by industry veterans to unify premium laboratory and office spaces with co-located vivarium facilities (managed by Charles River Labs), state-of-the-art shared equipment and research institute-level core facilities (provided by The ADA Forsyth Institute). Hatch.Bio Labs provides streamlined, responsive operational and scientific support, which is all conveniently managed through a proprietary and modern technology stack.

Purpose-built to meet the diverse needs of modern biotechnology companies, Hatch.Bio Labs offers solutions ranging from single laboratory benches to private suites for teams of over 40 people—all with flexible terms and affordable pricing. By significantly reducing operational burdens, Hatch.Bio Labs uniquely enables its residents to focus on achieving scientific milestones and accelerating their research, as evidenced by its 60+ residents raising 3.7 billion over the last 8 years.

A Hatch.Bio Resident experience in their own words:
"When we spun out of MIT and were searching for a home for our startup team, our wish was to find a place that synergistically combined what we loved at MIT—easy access to broad research facilities for biological, chemical, and pre-clinical work—with what industry could offer: a professionally managed office and lab.

After reviewing many incubators across Greater Boston, we moved to Hatch.Bio soon after its grand opening. It truly combines the best of both worlds: a best-in-class facility with a professionally managed lab, office, and support team, along with the academic advantages we loved at MIT—shared facilities, a BSL-2 lab, and a vivarium on the same floor!"
 — Hyunwoo Yuk, Co-Founder and CTO of SanaHeal

About Hatch.Bio Labs
Hatch.Bio Labs is a premier biotech incubation platform dedicated to reducing operational barriers. We offer flexible, cost-effective lab, office, and vivarium spaces integrated with scientific support and strategic partnerships. Our mission is to empower innovators to develop transformative technologies and accelerate biotech innovation. For more information or to schedule a tour, visit www.hatch.bio.

About North River Leerink
North River Leerink is a leading real estate investment and development firm specializing in life sciences and innovation spaces. The development of 100 Chestnut Street in the Brickbottom District demonstrates their commitment to creating environments that foster growth and collaboration within the biotech sector. For more information, visit www.northriverleerink.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hatchbio-labs-introduces-advanced-vivarium-facility-following-successful-site-launch-302509824.html

SOURCE Hatch.Bio Labs